Natera (NTRA) EBT Margin (2014 - 2026)
Natera (NTRA) reported EBT Margin of 12.17% for Q1 2026, up 113.0% on a YoY basis from 5.72% in Q1 2025, and down 507.96% quarter-over-quarter from 2.0% in Q4 2025.
Natera (NTRA) EBT Margin (2014 - 2026) Analysis & Trends
Natera has reported EBT Margin for 13 years, with the latest figure at 12.17% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin rose 113.0% year-over-year to 12.17%; the trailing twelve-month figure through Mar 2026 stood at 11.44% (down 110.0% YoY), and the FY2025 full-year result was 11.63%, down 44.0% from the prior year.
- EBT Margin for Q1 2026 stood at 12.17%, down from 2.0% in the prior quarter.
- The five-year high for EBT Margin was 2.0% in Q4 2025, with the low at 73.14% in Q2 2022.
- Historically, EBT Margin has averaged 31.67% across 5 years, with a median of 18.42% in 2025.
- Annual changes were most pronounced in 2022 — EBT Margin tumbled 2947 bps — and 2023, when it soared 4041 bps.
- Natera's EBT Margin stood at 65.43% in 2022, then jumped by 62 bps to 25.02% in 2023, then jumped by 54 bps to 11.58% in 2024, then surged by 83 bps to 2.0% in 2025, then sank by 508 bps to 12.17% in 2026.
- The last three EBT Margin figures came in at 12.17% (Q1 2026), 2.0% (Q4 2025), and 14.75% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -6.95% |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 15.76% |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 20.75% |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 31.16% |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 22.23% |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 7.90% |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | -12.17% |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 14.39% |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 22.14% |
| 10 | Quest Diagnostics | 21.68 Bn | 21.59 Bn | 942.00 Mn | 11.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.17% |
| Dec 31, 2025 | -2.00% |
| Sep 30, 2025 | -14.75% |
| Jun 30, 2025 | -18.42% |
| Mar 31, 2025 | -13.30% |
| Dec 31, 2024 | -11.58% |
| Sep 30, 2024 | -7.02% |
| Jun 30, 2024 | -8.85% |
| Mar 31, 2024 | -18.27% |
| Dec 31, 2023 | -25.02% |
| Sep 30, 2023 | -40.56% |
| Jun 30, 2023 | -42.50% |
| Mar 31, 2023 | -56.58% |
| Dec 31, 2022 | -65.43% |
| Sep 30, 2022 | -57.58% |
| Jun 30, 2022 | -73.14% |
| Mar 31, 2022 | -71.30% |
| Dec 31, 2021 | -81.26% |
| Sep 30, 2021 | -95.50% |
| Jun 30, 2021 | -81.52% |